Saccadometry of conditional rules in presymptomatic huntington's disease

Annals of the New York Academy of Sciences

Volumn 1164, Issue , 2009, Pages 444-450

  Robert, Matthieu P A ^a,b,c   Nachev, Parashkev C ^a,b   Hicks, Stephen L ^a,b   Golding, Charlotte V P ^a,b   Tabrizi, Sarah J ^b   Kennard, Christopher ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Biomarker; Huntington's disease; Latency; Preclinical; Saccade

Indexed keywords

BIOLOGICAL MARKER;

ADULT; CLINICAL ARTICLE; COGNITIVE DEFECT; CONFERENCE PAPER; CONTROLLED STUDY; DEVICE; EYE MOVEMENT; EYE MOVEMENT CONTROL; FEMALE; HETEROZYGOTE; HUMAN; HUNTINGTON CHOREA; INFRARED RADIATION; LATENT PERIOD; MALE; MORPHOMETRICS; PHENOTYPE; SACCADIC EYE MOVEMENT; SACCADOMETRY; TASK PERFORMANCE;

EID: 66149147790     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2008.03736.x     Document Type: Conference Paper

References (21)

1. Huntington, G. 1872. On chorea. Med. Surg. Rep. 26 : 320 321.
2. Walker, F.O. 2007. Huntington's disease. Lancet 369 : 218 228.
3. Aylward, E.H. et al. 2004. Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology 63 : 66 72.
4. Hedreen, J.C. S.E. Folstein. 1995. Early loss of neostriatal striosome neurons in Huntington's disease. J. Neuropathol. Exp. Neurol. 54 : 105 120.
5. Vonsattel, J.P. et al. 1985. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44 : 559 577.
6. The Huntington's Disease Collaborative Research Group 1993. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72 : 971 983.
7. Langbehn, D.R. et al. 2004. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin. Genet. 65 : 267 277.
8. Wild, E.J. S.J. Tabrizi. 2006. Predict-HD and the future of therapeutic trials. Lancet Neurol. 5 : 724 725.
9. Aron, A.R. et al. 2003. Task-set switching deficits in early-stage Huntington's disease: implications for basal ganglia function. J. Cogn. Neurosci. 15 : 629 642.
10. Aylward, E.H. 2007. Change in MRI striatal volumes as a biomarker in preclinical Huntington's disease. Brain Res. Bull. 72 : 152 158.
11. Douaud, G. et al. 2006. Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study. Neuroimage 32 : 1562 1575.
12. Kloppel, S. et al. 2008. White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease. Brain 131 : 196 204.
13. Ober, J.K. et al. 2003. Hand-held system for ambulatory measurement of saccadic durations of neurological patients. In Modelling and Measurement in Medicine. J. Gajda, Ed. : 187 198. Komitet Biocybernityki i Inzyneierii Biomedycznej PAN. Warsaw.
14. Carpenter, R.H. 1988. Movements of the Eyes. Pion. London.
15. Carpenter, R.H. M.L. Williams. 1995. Neural computation of log likelihood in control of saccadic eye movements. Nature 377 : 59 62.
16. Ali, F.R. et al. 2006. The use of quantitative oculometry in the assessment of Huntington's disease. Exp. Brain Res. 169 : 237 245.
17. Antoniades, C.A. et al. 2007. Saccadometry: a new tool for evaluating presymptomatic Huntington patients. Neuroreport 18 : 1133 1136.
18. Blekher, T. et al. 2006. Saccades in presymptomatic and early stages of Huntington disease. Neurology 67 : 394.
19. Golding, C.V.P. et al. 2006. Identification of an oculomotor biomarker of preclinical Huntington disease. Neurology 67 : 485.
20. Peltsch, A. et al. 2008. Saccadic impairments in Huntington's disease. Exp. Brain Res. 186 : 457 469.
21. Hicks, S.L. et al. 2008. Oculomotor deficits indicate the progression of Huntington's disease. Prog Brain Res. 171 : 555 558.